Celgene Corporation to Webcast at Upcoming Investor Conferences
February 27 2017 - 7:30AM
Business Wire
Celgene Corporation (NASDAQ:CELG) plans to present at two
upcoming investor conferences where Celgene management will provide
an overview of the Company. The conferences will be webcast live
and will be available in the Investor Relations section of the
Company’s website at www.celgene.com.
Wednesday, March 8, 2017, Celgene will present at the Cowen 37th
Annual Health Care Conference in Boston at 8:40 AM ET
Wednesday, March 15, 2017, Celgene will present at the Barclays
Global Healthcare Conference 2017 in Miami at 10:15 AM ET
About Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in
the discovery, development and commercialization of innovative
therapies for the treatment of cancer and inflammatory diseases
through next-generation solutions in protein homeostasis,
immuno-oncology, epigenetics, immunology and neuro-inflammation.
For more information, please visit www.celgene.com. Follow Celgene
on Social Media: @Celgene, Pinterest, LinkedIn, Facebook and
YouTube.
Forward-Looking Statements
This press release contains forward-looking statements, which
are generally statements that are not historical facts.
Forward-looking statements can be identified by the words
"expects," "anticipates," "believes," "intends," "estimates,"
"plans," "will," “outlook” and similar expressions. Forward-looking
statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are
made. We undertake no obligation to update any forward-looking
statement in light of new information or future events, except as
otherwise required by law. Forward-looking statements involve
inherent risks and uncertainties, most of which are difficult to
predict and are generally beyond our control. Actual results or
outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of
factors, many of which are discussed in more detail in our Annual
Report on Form 10-K and our other reports filed with the Securities
and Exchange Commission.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170227005664/en/
Celgene CorporationPatrick E. Flanigan III(908)
673-9969Corporate VP, Investor RelationsorBrian Gill(908)
673-9530VP, Corporate Communications
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Apr 2023 to Apr 2024